STOCK TITAN

Wrap Technologies (Nasdaq: WRAP) makes $2M Frenel investment and gains exclusive U.S., NATO rights

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Wrap Technologies, Inc. entered into a securities purchase agreement with Frenel Imaging Ltd. and other investors, under which it acquired 74,918 Series A Preferred Shares of Frenel at $26.6959 per share for an aggregate $2,000,000, including $300,000 previously advanced. Investors collectively hold an irrevocable option to invest up to an additional $2,500,000 in Series A-2 Preferred Shares based on an $18,500,000 pre-money valuation within 24 months. The Preferred Shares are convertible into ordinary shares, carry voting rights on an as-converted basis, include a liquidation preference, and are subject to automatic conversion upon an IPO; while Wrap holds at least 80% of the Preferred Shares, it also has right-of-first-refusal and co-sale rights.

Concurrently, Wrap entered an exclusive distribution license with Frenel, granting Wrap exclusive rights to market, sell, distribute, integrate, and provide Frenel’s thermal-polarimetric image-processing software in the United States and, via U.S. Foreign Military Financing and Foreign Military Sales, to NATO customers. Exclusivity runs for an initial four-year period and depends on performance milestones, including operational and business development targets by 12 and 24 months and cumulative net revenue to Frenel from Wrap-executed sales exceeding $3,000,000 by 36 months, after which failure triggers conversion to a non-exclusive license. The deal includes a revenue-share structure, termination and change-of-control provisions, a 12‑month tail period on certain prospects, key-person involvement requirements, and customary IP, indemnification, and confidentiality terms. Wrap also entered an amended investors’ rights agreement with Frenel shareholders and announced the launch of WrapShield, an autonomous defense and public safety platform anchored by the Frenel investment and license.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Frenel Series A Preferred Shares purchased 74,918 shares Aggregate Series A Preferred Shares acquired by Wrap in the private placement
Purchase price per Preferred Share $26.6959 per share Price paid by Wrap for each Frenel Series A Preferred Share
Aggregate purchase price $2,000,000 Total consideration for Frenel Preferred Shares, including prior advance investment
Advance investment amount $300,000 Portion of the $2,000,000 previously paid under an advance investment and interim license
Optional additional investments pool $2,500,000 Maximum aggregate amount of optional Series A-2 investments available to all investors
Series A-2 pre-money valuation $18,500,000 Pre-money valuation basis for pricing Series A-2 Preferred Shares on a fully diluted basis
Exclusivity revenue milestone $3,000,000 Cumulative net revenue to Frenel from Wrap-executed sales required by 36 months
Optional investment exercise period 24 months Time after initial closing during which investors may exercise optional Frenel investments
Series A Preferred Shares financial
"the Company purchased in a private placement an aggregate of 74,918 Series A Preferred Shares"
Series A preferred shares are an early-stage class of ownership sold to investors that gives them special protections and payment priority over regular common stock. Think of them as a safer seat on a bus: if the company earns money or is sold, holders get paid before ordinary shareholders, and they often can convert to common shares later to share upside; that mix of safety and growth potential helps investors manage risk and reward.
pre-money valuation financial
"purchase price for the A-2 Preferred Shares will be based on a pre-money valuation of $18,500,000"
Pre-money valuation is the estimated worth of a company before it receives any new investment. It can be thought of as the company's value right before adding fresh money, similar to valuing a house before a renovation. This figure helps investors understand how much of the company they will own after investing and how their investment impacts the company's overall value.
exclusive distribution license agreement regulatory
"the Company and Frenel entered into an exclusive distribution license agreement"
right of first refusal financial
"the Company is entitled to...a right of first refusal and co-sale rights with respect to any sale"
A right of first refusal gives an existing shareholder or party the chance to buy an asset or shares before the owner can sell them to someone else. Think of it like being offered the first option to buy a house when the owner decides to sell; it matters to investors because it can limit who can acquire a stake, slow or block transactions, and affect the price and liquidity of an investment by restricting open-market sales or new buyers.
Foreign Military Financing regulatory
"to NATO agencies and member-state customers through U.S. Department of Defense-funneled Foreign Military Financing"
counter-UAS technical
"The initial application is counter-UAS, with an architecture designed to expand"
Counter-UAS (counter-unmanned aircraft systems) are tools and tactics used to detect, track, and disable or divert drones that pose a threat to people, property, or operations. Think of them as a combination of a security camera, alarm system, and net that can find an unwanted flying device and stop it before it causes harm. Investors care because demand, regulation, and deployment of these systems affect revenue, contract opportunities, legal risk, and the valuation of companies that build or use them.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What investment did Wrap Technologies (WRAP) make in Frenel Imaging Ltd.?

Wrap invested $2,000,000 in Frenel Imaging Ltd., acquiring 74,918 Series A Preferred Shares at $26.6959 per share. This amount includes $300,000 previously paid under an advance investment and interim limited license agreement between the two companies.

What optional additional investment rights exist for WRAP under the Frenel agreement?

Under the purchase agreement, all investors collectively may make additional investments of up to $2,500,000 in Frenel’s Series A-2 Preferred Shares. These optional investments are exercisable within 24 months and are priced using a $18,500,000 pre-money valuation on a fully diluted basis.

What territories are covered by Wrap Technologies’ exclusive license with Frenel?

The exclusive license grants Wrap rights in the United States and, outside the U.S., to NATO agencies and member-state customers through U.S. Foreign Military Financing and Foreign Military Sales transactions. The initial exclusivity period is four years, subject to performance milestones.

What milestones must Wrap Technologies (WRAP) meet to maintain exclusivity under the Frenel license?

Wrap must meet staged milestones, including operational and business development targets by 12 and 24 months and achieving cumulative net revenue to Frenel from Wrap-driven sales of more than $3,000,000 by 36 months. Failure, after cure periods, converts the license from exclusive to non-exclusive.

How is revenue handled under the Wrap–Frenel Exclusive Distribution License Agreement?

For Frenel-sourced products, pricing includes a quoted base price plus a 10% revenue share of net funds invoiced to the end customer; for U.S. or alternative supply chain products, Frenel similarly receives its base price plus a 10% revenue share. The agreement states this revenue share is the sole compensation to Wrap.

What is WrapShield and how does Frenel’s technology fit into WRAP’s strategy?

WrapShield is an autonomous defense and public safety platform intended to connect detection, decision, and response across complex environments. Frenel’s TPiCore thermal-polarimetric imaging is the initial detection layer, with WRAP holding exclusive U.S. and NATO commercialization rights as part of its strategic investment and license.
false 0001702924 0001702924 2026-07-07 2026-07-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 7, 2026

 

WRAP TECHNOLOGIES, INC.

(Exact name of Registrant as specified in its Charter)

 

Delaware   001-38750   98-0551945

(State or other jurisdiction

of incorporation)

 

(Commission

File No.)

 

(IRS Employer

Identification No.)

 

3480 Main Hwy, Suite 202, Miami, Florida 33133

(Address of principal executive offices) (Zip code)

 

(800) 583-2652

(Registrant’s Telephone Number)

 

Not Applicable

(Former name or address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   WRAP   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2)

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

Frenel Investment

 

On July 7, 2026, Wrap Technologies, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) by and among the Company, Frenel Imaging Ltd., a company incorporated under the laws of the State of Israel (“Frenel”), and the other investors (the “Investors”)listed on the signature pages thereto, pursuant to which, (the “Investors”).Pursuant to the Purchase Agreement, the Company purchased in a private placement an aggregate of 74,918 Series A Preferred Shares, par value NIS 0.01 per share (the “Preferred Shares”), of Frenel at a purchase price of $26.6959 per share, for an aggregate purchase price of $2,000,000 ($300,000 of which was already paid by the Company pursuant to that certain advance investment and interim limited license agreement, dated as of March 6, 2026, by and between the Company and Frenel) (collectively, the “Financing Transaction”). The closing of the Financing Transaction occurred on July 8, 2026 (the “Closing Date”).

 

Pursuant to the Purchase Agreement, each Investor has an irrevocable right, but not the obligation, to make additional investments in Frenel in one or more additional closings of up to an aggregate of $2,500,000 collectively among all Investors, in consideration for Series A-2 Preferred Shares (“A-2 Preferred Shares”), par value NIS 0.01 per share, of Frenel, having the same rights, restrictions, preferences, privileges, and protections as the Preferred Shares. Such additional investment right may be exercised at any time until twenty-four (24) months following the initial closing under the Purchase Agreement, and the purchase price for the A-2 Preferred Shares will be based on a pre-money valuation of $18,500,000 on a fully diluted basis, determined immediately following the deferred closing. If the aggregate optional investment amounts subscribed for by all Investors exceed $2,500,000, each participating Investor’s optional investment amount will be reduced pro rata based on the respective financing amounts of the participating Investors.

 

The Purchase Agreement contains certain representations and warranties, covenants and indemnification provisions customary for similar transactions. The representations, warranties and covenants contained in the Purchase Agreement were made solely for the benefit of the applicable parties to the Purchase Agreement and may be subject to limitations agreed upon by the applicable contracting parties.

 

Preferred Shares

 

The rights, restrictions, preferences, privileges, and protections of the Preferred Shares are governed by the Amended and Restated Articles of Association of Frenel (the “Articles”).the Preferred Shares are convertible into ordinary shares of Frenel, par value NIS 0.01 per share (“Ordinary Shares”), at any time at the option of the holder thereof, subject to certain exceptions, at the conversion price of $26.6959, subject to certain adjustments as provided for in the Articles.

 

The holders of Preferred Shares are entitled to vote on an as-converted to Ordinary Shares basis with holders of ordinary shares of Frenel, par value NIS 0.01 per share (“Ordinary Shares”).

 

In the event that dividends are declared and distributed, holders of Preferred Shares shall be entitled to receive dividends pari passu, on an as-converted basis, with the holders of Ordinary Shares. In the event of a liquidation, dissolution or winding up of Frenel, the holders of Preferred Shares are entitled to receive, on a pari-passu basis (based upon shares held on an as converted basis) prior and in preference to the holders of Ordinary Shares, out of available funds an amount per share equal to the greater of (i) $26.6959 (and all declared but unpaid dividends, if any) and less prior dividends or distributions (the “Preferred Preference Amount”), or (ii) the amount per Preferred Share that each holder thereof would have been entitled to had such Preferred Share been converted into Ordinary Shares (without having to actually convert) (the “Pro Rata Amount”). The Preferred Shares will be automatically converted to Ordinary shares upon an initial public offering of the Ordinary Shares. Pursuant to the Articles, the Company is entitled to, prior to any initial public offering of the Ordinary Shares and so long as the Company holds at least 80% of the Preferred Shares, a right of first refusal and co-sale rights with respect to any sale of shares of Frenel.

 

 

 

 

Amended and Restated Investors’ Rights Agreement

 

In connection with the Purchase Agreement, the Company entered into an Amended and Restated Investors’ Rights Agreement, dated July 7, 2026, by and among the Company, Frenal and other certain Frenel shareholders (the “IRA”). Pursuant to the IRA, the Company was granted certain additional rights as a holder of the Preferred Shares, including, among others, registration rights, information rights and inspection rights, subject to certain confidentiality obligations.

 

Exclusive Distribution License Agreement

 

On July 7, 2026 (the “Effective Date”), the Company and Frenel entered into an exclusive distribution license agreement (the “License Agreement”), pursuant to which, Frenel granted to the Company an exclusive license to market, sell, distribute, integrate, and provide Frenel’s proprietary image processing software for polarimetric thermal imaging (the “Company Product”) to customers within the United States of America (the “Territory”) and, outside the Territory, to NATO agencies and member-state customers through U.S. Department of Defense-funneled Foreign Military Financing and Foreign Military Sales transactions (“NATO Customers”).

 

The distribution license is exclusive for an initial exclusivity period of four (4) years from the Effective Date, subject to the Company’s continuous satisfaction of certain minimum annual commitment milestones described below. The License Agreement commences on the Effective Date and continues until terminated in accordance with its terms. Certain pre-existing relationships of Frenel (the “Excluded Relationships”), including engagements with DRS/RADA/Leonardo DRS, Redwire Inc., Polaris Sensor Technologies, Moxtek, Sierra Olympia Technologies, Eoptic, Atlantic Bridge Solutions/ANC Group, and CET Sandbox, are excluded from the exclusivity grant for an initial period of twelve (12) months (extendable by an additional six months) during which Frenel may convert those relationships into definitive agreements. After such period, any unconverted Excluded Relationships become subject to the Company’s exclusive distribution rights.

 

The Company’s exclusivity is conditioned upon meeting certain performance milestones. By the twelve (12)-month anniversary of the Effective Date, the Company must establish a U.S. value chain and marketing base, complete at least three (3) product demonstrations, initiate at least one (1) active pilot program, respond to at least one (1) request for quotation, and conduct at least ten (10) meetings with high-level decision makers. By the twenty-four (24) month anniversary, the Company must have executed at least one (1) customer agreement for the purchase or subscription of the Company Product. By the thirty-six (36) month anniversary, cumulative net revenue to Frenel from sales executed by the Company must exceed $3,000,000. Failure to achieve any milestone, after applicable cure periods of 120 days for the first milestone and 90 days for subsequent milestones, results in the automatic conversion of the exclusive license to a non-exclusive license for the remainder of the term.

 

Either party may terminate the License Agreement upon a material breach by the other party that remains uncured for thirty (30) days following written notice. Frenel may terminate if the Company fails to meet the minimum annual commitments (commencing at the second anniversary of the Effective Date) upon thirty (30) days’ notice. Either party may terminate immediately upon the other’s bankruptcy or insolvency. Frenel may also terminate upon ninety (90) days’ notice if the Company undergoes a change of control in which the acquirer is a direct competitor of Frenel. Upon termination (other than for the Company’s breach), the Company is entitled to a twelve (12)-month “Tail Period” during which it continues to receive its revenue share on up to ten (10) advanced customer prospects then pending.

 

For products sourced from Frenel’s Israeli operations, the Company has agreed to pay Frenel a quoted base price plus a ten percent (10%) revenue share of net funds invoiced to the end customer. For U.S. sourced or alternative supply chain products, Frenel receives its base price (as mutually agreed) plus a ten percent (10%) revenue share of net funds. The revenue share constitutes the sole and exclusive compensation to the Company under the License Agreement. Payments are due within thirty (30) days of the Company’s receipt of corresponding customer payments and a valid invoice from Frenel.

 

 

 

 

The License Agreement requires that Scot Cohen, the Company’s Chairman and Chief Executive Officer, and Jared Novick, the Company’s President and Chief Operating Officer, remain materially and actively involved in the Company’s performance under the License Agreement during the term and any applicable Tail Period. A material reduction in the involvement of either key person triggers notice and replacement procedures. If such a reduction is not resolved within the prescribed period, Frenel may convert the exclusive license to a non-exclusive license upon forty-five (45) days’ written notice.

 

Pursuant to the License Agreement, Frenel retains all intellectual property rights in the Company Product and related proprietary technology. The Company retains all rights in its own intellectual property. Any intellectual property jointly developed under a separate statement of work will be jointly owned by the parties.

 

The License Agreement also contains customary representations and warranties, indemnification provisions, confidentiality obligations, non-compete restrictions, and other miscellaneous terms customary for similar transactions.

 

The foregoing descriptions of terms and conditions of the Purchase Agreement, the IRA and the License Agreement do not purport to be complete and are qualified in their entirety by the full text of the Purchase Agreement, the IRA and the License Agreement, copies of which are attached hereto as Exhibits 10.1, 10.2 , and 10.3 respectively.

 

Item 8.01 Other Events.

 

On July 7, 2026, the Company issued a press release announcing the License Agreement. A copy of the press release is attached as Exhibit 99.1 hereto.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
10.1*   Securities Purchase Agreement, dated July 7, 2026, by and among the Company, Frenel Imaging Ltd. and certain other investors listed on the signature paged thereto
10.2*   Amended and Restated Investors’ Rights Agreement, dated July 7, 2026, by and among the Company, Frenel Imaging Ltd. and certain Frenel Imaging Ltd. shareholders listed on the signature pages thereto.
10.3*   Exclusive Distribution and License Agreement, dated July 7, 2026, by and between the Company and Frenel Imaging Ltd.
99.1   Press Release, dated July 7, 2026.
104   Cover Page Interactive Data File (formatted as Inline XBRL)

 

* Certain of the schedules (and similar attachments) to this exhibit have been omitted in accordance with Item 601(a)(5) of Regulation S-K under the Securities Act because they do not contain information material to an investment or voting decision and that information is not otherwise disclosed in the exhibit or the disclosure document. The registrant hereby agrees to furnish a copy of all omitted schedules (or similar attachments) to the SEC upon its request.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  WRAP TECHNOLOGIES, INC.
     
Date: July 13, 2026 By: /s/ Scot Cohen
    Scot Cohen
    Chief Executive Officer and Chairman of the Board

 

 

 

 

Exhibit 99.1

 

WRAP Launches WrapShield: An Autonomous Defense & Public Safety Platform, Beginning with Advanced Thermal Polarimetric Sensing for Counter-UAS and Expanding Across AI-Enabled Security Responses

 

WRAP anchors the platform with a strategic investment in Frenel Imaging Ltd., securing WRAP exclusive U.S. and NATO commercialization rights to TPiCore® thermal-polarimetric sensing and establishing the detection layer for WrapShield and potential future responses across every domain

 

MIAMI, July 07, 2026 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (Nasdaq: WRAP) (“Wrap” or, the “Company”), a global public safety technology company, today launched WrapShield, an autonomous defense and public safety platform designed to detect threats earlier, orchestrate the response, and act with proportionate, mission-appropriate action; built on the conviction that this decade’s defining threats, from the battlefield to the homeland, will be solved not by better individual devices but by an intelligent operating layer connecting detection to response.

 

WrapShield represents the next evolution of WRAP – from a company recognized for innovative non-lethal tools to a platform company connecting advanced sensing, artificial intelligence, command-and-control, and response technologies into a unified operating architecture for public safety, homeland security, defense, and critical infrastructure.

 

To stand up the platform’s detection layer, WRAP announced a strategic investment in Frenel Imaging Ltd. (“Frenel”), an Israeli advanced-sensing company, together with an exclusive U.S. and NATO license to Frenel’s proprietary TPiCore® thermal-polarimetric imaging. Frenel is expected to be the first of many planned investments into WrapShield. WRAP believes it identified the market’s blind spot early and secured access before the U.S. market fully understood this newly validated operational technology. Already in operational use in Israel, Frenel’s technology brings WRAP access to a sensing capability that the Company believes is relevant to U.S. defense and public safety markets.

 

WrapShield is an autonomous defense and public safety platform intended to serve as an operating layer that connects detection, decision, and response across complex operational environments. WrapShield is designed to enable government agencies to integrate existing and future sensors, AI capabilities, and response technologies into a unified operational ecosystem.

 

Detect: Advanced multi-modal sensing beginning with Frenel’s TPiCore® thermal-polarimetric imaging and AI edge processing, with an architecture designed to incorporate additional sensing technologies over time.
   
Orchestrate: AI-assisted, human-supervised threat detection, classification, and decision support that fuses sensor data, assesses threats, and recommends proportionate courses of action while interoperating with government and third-party command-and-control systems.
   
Respond: A response layer capable of integrating WRAP’s own technologies as well as third-party and government response capabilities – kinetic or non-kinetic, lethal or non-lethal, autonomous or human-directed – based on mission requirements, rules of engagement, and customer preferences. The initial application is counter-UAS, with an architecture designed to expand across defense, public safety, critical infrastructure, border security, and other autonomous security missions.

 

 
 

 

The platform’s advantage begins with physics. Conventional thermal cameras generally read one dimension of infrared data – intensity; TPiCore® is designed to read a additional data layers, capturing the polarization of thermal radiation at the pixel level to support reconstruction for each object’s physical characteristics and material composition. The Company believes this polarimetric fingerprint cannot be spoofed, jammed, or turned off, and requires no RF signal to detect. Frenel’s technology implements real-time processing on edge hardware across drone, ground, fixed-site, naval, and handheld configurations.

 

“We believe the polarimetric fingerprint of an object is as immutable as its molecular composition — it cannot be spoofed, jammed, or turned off. WRAP is the right partner to scale this capability across the U.S. and NATO” said Sagi Zur Arie, Founder & Chief Technology Officer, Frenel.

 

For two decades these were nation-state problems – engineered abroad, fought on foreign battlefields, and countered almost exclusively by the U.S. military. We believe that era is over: the same autonomous, RF-silent systems now cross the U.S. border, loiter over domestic airspace, and probe critical infrastructure at home – and defending against them is no longer the military’s job alone: homeland security, critical infrastructure, and public safety must all be able to detect, orchestrate, and respond. The most dangerous of these systems may carry no radio link, rendering them invisible to the RF-based detection the counter-UAS market is built on. WrapShield is designed to help address that blind spot.

 

“WrapShield represents our long-term vision for the future of defense and public safety,” said Scot Cohen, Chief Executive Officer of WRAP. “We’re beginning with one of the most urgent operational challenges facing the world today – countering the rapidly growing threat posed by unmanned aircraft systems. As asymmetric threats become more accessible to lone actors and sophisticated adversaries alike, our customers need platform-level solutions that match the speed, scale, and economics of the threat. WrapShield is our answer: an autonomous platform that is designed to enable earlier detection, AI-assisted decision support, and integration with the response technologies our customers trust. Frenel’s advanced thermal polarimetric sensing technology is the first building block in what we believe will become a foundational platform for the next generation of defense and public safety.”

 

A Sensing Capability Applicable Across Emerging Security and Autonomous Markets

 

Thermal polarimetric sensing is the next level of Visual Actionable Intelligence with applicability extending well beyond traditional public safety environments. Illustrative markets and applications include:

 

Defense Intelligence, Surveillance, and Reconnaissance (ISR)
   
Counter-Unmanned Aircraft Systems (Counter-UAS)
   
Autonomous Ground, Maritime, and Aerial Vehicles
   
Maritime Domain Awareness
   
Persistent Surveillance Missions
   
AI-Enabled Perception Systems
   
Robotics and Autonomous Platforms
   
Military and Allied Defense Applications
   
Border Security
   
Critical Infrastructure Protection
   
Industrial Monitoring
   
Advanced Remote Sensing Architectures
   
Airborne and Persistent Observation Missions

 

 
 

 

Because thermal polarimetric sensing measures characteristics inherent to physical materials rather than solely thermal intensity, management believes it is positioned as the underlying technology that will support future applications ranging from ground-based security operations to airborne remote sensing architectures, persistent observation missions, and intelligent autonomous systems where advanced material discrimination, anomaly detection, and situational awareness are increasingly important.

 

About Frenel Imaging Ltd.

 

Frenel Imaging Ltd. specializes in polarimetric thermal imaging for defense, security, and precision-sensing applications. Its Division of Focal Plane (DoFP) architecture delivers simultaneous polarimetric and thermal data at the pixel level, processed in real time on deployable edge hardware. Frenel is a 2024 SPIE Prism Award recipient and NVIDIA Inception Program member. www.frenel.ai

 

About Wrap Technologies, Inc.

 

Wrap Technologies, Inc. (Nasdaq: WRAP) a global leader in innovative public safety technologies and non-lethal tools, delivering cutting-edge technology with exceptional people to address the complex, modern day challenges facing public safety organizations.

 

WRAP’s complete public safety portfolio includes the non-lethal BolaWrap® 150 device, Wrap Reality® immersive training platform, WrapVision™ body-worn camera system, WrapTactics™ training programs, and next-generation C-UAS solutions like the 1KC Kinetic Anti-Drone Cassette, all of which supports the Company’s mission to provide safer, scalable, and cost-effective technologies for public safety, defense, and critical infrastructure markets.

 

With a growing demand for non-lethal tools and techniques to create time, distance and tactical advantage in non-criminal calls, Wrap’s BolaWrap® 150 incorporates a multi-sensory distraction of sight and sound as a first response, followed by a non-lethal restraint if further escalation is required. This approach reduces the risk of injury to officers, subjects, and the community.

 

Wrap’s BolaWrap® 150 solution is intended to provide law enforcement with a safer choice for nearly every phase of a critical incident. This innovative, patented device deploys a multi-sensory, cognitive disruption to expand the pre-escalation period and gives officers the advantage and critical time to manage non-compliant subjects before resorting to higher-force options. The BolaWrap® 150 is not pain-based compliance. It does not shoot, strike, shock, or incapacitate, instead, it helps officers strategically operate pre-escalation on the force continuum, reducing the risk of injury to both officers and subjects. Used by over 1,000 agencies across the U.S. and in 60 countries, BolaWrap® is backed by training certified by the International Association of Directors of Law Enforcement Standards and Training (IADLEST), reinforcing Wrap’s commitment to public safety through cutting-edge technology and expert training.

 

WrapReality™ VR is a fully immersive training simulator to enhance decision-making under stress.

 

As a comprehensive public safety training platform, it provides first responders with realistic, interactive scenarios that reflect the evolving challenges of modern law enforcement. By offering a growing library of real-world situations, WrapReality™ is intended to equip officers with the skills and confidence to navigate high stakes encounters effectively, which we believe leads to safer outcomes for both responders and the communities they serve.

 

 
 

 

WrapVision is an all-new body-worn camera and evidence management system built for efficiency.

 

Designed for efficiency, security, and transparency to meet the rigorous demands of modern law enforcement, WrapVision captures, stores, and helps manage digital evidence, ensuring operational security, regulatory compliance, and enhanced video picture quality and field of view.

 

The WrapVision camera, powered by IONODES, boasts streamlined cloud integration and final North American assembly, with a critical made-in-America roadmap projected for early 2026. This track helps ensure data integrity and helps eliminate critical concerns over unauthorized access or foreign surveillance risks.

 

Trademark Information

 

WRAP, the Wrap logo, BolaWrap®, Non-Lethal Response™, WrapReality™, Wrap Training Academy, and Non-Lethal Response™ are trademarks of WRAP Technologies, Inc., some of which are registered in the U.S. and abroad. All other trade names used herein are either trademarks or registered trademarks of the respective holders.

 

Cautionary Note on Forward-Looking Statements - Safe Harbor Statement

 

This release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Words such as “expect,” “anticipate,” “should”, “believe”, “target”, “project”, “goals”, “estimate”, “potential”, “predict”, “may”, “will”, “could”, “intend”, and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements include, but are not limited to, statements relating to the Company’s strategic investment in Frenel; the expected benefits, effects, limitations, and implications of TPiCore® thermal-polarimetric imaging and WrapShield; expected commercialization, integration, deployment, market adoption, and expansion of WrapShield; the Company’s ability to develop, integrate, manufacture, sell, and support current and future products and technologies; the intended performance, benefits, and safety outcomes of the Company’s products and training solutions; expected market opportunities; and the Company’s planned future products, technologies, integrations, product designs, and related benefits. The Company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company’s ability to maintain compliance with the Nasdaq Capital Market’s listing standards; the Company’s ability to successfully implement training programs for the use of its products; the Company’s ability to manufacture and produce products for its customers; the Company’s ability to develop sales for its products; market acceptance of existing and future products; changes in law enforcement budgets, policies, procurement practices, and use-of-force standards; the availability of funding to continue to finance operations; the complexity, expense, and time associated with sales to law enforcement and government entities; the lengthy evaluation and sales cycle for the Company’s product solutions; product defects; litigation risks from alleged product-related injuries; risks of government regulations and changes in regulatory classifications or interpretations; the impact resulting from geopolitical conflicts and any resulting sanctions; the ability to obtain export licenses for countries outside of the United States; the ability to obtain patents and defend intellectual property against competitors; the impact of competitive products and solutions; and the Company’s ability to maintain and enhance its brand, as well as other risk factors mentioned in the Company’s most recent annual report on Form 10-K, subsequent quarterly reports on Form 10-Q, and other Securities and Exchange Commission filings. These forward-looking statements are made as of the date of this release and were based on current expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events, or changes in its expectations.

 

Investor Relations Contact:

 

(800) 583-2652

ir@wrap.com wrap.com

 

 

Filing Exhibits & Attachments

7 documents